Glioblastoma News and Research

RSS
Glioblastoma is the most aggressive and malignant form of glioma, a type of primary brain cancer. Surgery is often used to treat gliomas, along with radiation. However, since surgery and radiation fail to cure the disease, doctors may turn to additional radiation or chemotherapy. In early stages glioblastoma tumors often grow without symptoms and therefore can become quite large before symptoms arise. When the tumor becomes symptomatic, tumor growth is usually very rapid and is accompanied by altered brain function, and if left untreated the disease becomes lethal. Although primary treatment is often successful in temporarily stopping the progression of the tumor, glioblastomas almost always recur and become lethal.
Study sheds light on key protein involved in memory formation and brain growth

Study sheds light on key protein involved in memory formation and brain growth

Enzyme inhibitor and chemotherapy combination regresses glioblastoma

Enzyme inhibitor and chemotherapy combination regresses glioblastoma

Combination chemotherapy increases survival in animal models of glioblastoma

Combination chemotherapy increases survival in animal models of glioblastoma

Researchers block common siren call of glioblastoma and metastatic breast cancer

Researchers block common siren call of glioblastoma and metastatic breast cancer

Circadian rhythms could hold key to novel treatments for glioblastoma

Circadian rhythms could hold key to novel treatments for glioblastoma

Nanobiotix receives FDA approval for first immuno-oncology trial

Nanobiotix receives FDA approval for first immuno-oncology trial

Higher ‘mutational burden’ of tumors predicts success rate with cancer immunotherapies

Higher ‘mutational burden’ of tumors predicts success rate with cancer immunotherapies

Certain brain tumor patients more likely to receive short hospice services, study finds

Certain brain tumor patients more likely to receive short hospice services, study finds

New scalp device delivering electric fields improves survival in patients with glioblastoma

New scalp device delivering electric fields improves survival in patients with glioblastoma

Electric fields therapy leads to better overall, progression-free survival in glioblastoma patients

Electric fields therapy leads to better overall, progression-free survival in glioblastoma patients

Researchers identify novel mechanism that protects from brain tumor

Researchers identify novel mechanism that protects from brain tumor

Study provides new insights into mechanism of tumor survival in glioblastoma

Study provides new insights into mechanism of tumor survival in glioblastoma

Researchers identify vulnerability for glioblastoma subtypes

Researchers identify vulnerability for glioblastoma subtypes

New cancer drug begins clinical trial in human patients with rare brain tumor

New cancer drug begins clinical trial in human patients with rare brain tumor

New biomarker could lead to early detection of Alzheimer's disease

New biomarker could lead to early detection of Alzheimer's disease

Preclinical studies show effectiveness of targeted therapy for glioblastoma

Preclinical studies show effectiveness of targeted therapy for glioblastoma

Genome-wide molecular tests can guide treatment in recurrent glioblastoma, study shows

Genome-wide molecular tests can guide treatment in recurrent glioblastoma, study shows

‘Precision Medicine’ may not always be so precise when applied to diverse populations, study says

‘Precision Medicine’ may not always be so precise when applied to diverse populations, study says

Arsenic trioxide could be powerful therapy to extend lives of certain glioblastoma patients

Arsenic trioxide could be powerful therapy to extend lives of certain glioblastoma patients

Scientists receive critical funding to study treatments for three deadly cancers

Scientists receive critical funding to study treatments for three deadly cancers

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.